Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
16.04.2003 - 29.07.2003
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study
Qualifier:
according to
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
adopted JuIy 17, 1992
Deviations:
no
Qualifier:
according to
Guideline:
EU Method B.6 (Skin Sensitisation)
Version / remarks:
JuIy 30, 1996
Deviations:
no
Qualifier:
according to
Guideline:
EPA OPPTS 870.2600 (Skin Sensitisation)
Version / remarks:
August 1998
Deviations:
no
GLP compliance:
yes (incl. certificate)
Type of study:
guinea pig maximisation test
Species:
guinea pig
Strain:
other: Hsd Poc: DH (SPF)
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, Germany
- Age at study initiation: About 5 weeks
- Weight at study initiation: 260 g - 337 g
- Housing: 5 animals per cage, stainless steel wire mesh cages with plastic-coated grating, minimum floor area: 2000 cm²,
- Diet: Kliba Labordiaet (Kaninchen/ Meerschweinchen-Haltungsdiaet) Provimi Kliba SA, Kaiseraugst, Switzerland, ad libitum
- Water: Tap water, ad libitum
- Acclimation period: 6 days before the first test substance application

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12h/12h


Route:
intradermal and epicutaneous
Vehicle:
CMC (carboxymethyl cellulose)
Concentration / amount:
5% test substance in 1% CMC for intradermal induction,
25% test substance in 1% CMC for epicutaneous induction and challenge
Route:
epicutaneous, occlusive
Vehicle:
CMC (carboxymethyl cellulose)
Concentration / amount:
5% test substance in 1% CMC for intradermal induction,
25% test substance in 1% CMC for epicutaneous induction and challenge
No. of animals per dose:
test group: 10, control group: 5
Details on study design:
PREPARATION OF THE TEST SUBSTANCE FORMULATIONS
The test substance preparations were produced on a weight by weight (w/w) basis shortly before the application by stirring with a high speed homogenizer (Ultra-Turrax) and a magnetic stirrer.
The homogeneity of the test substance preparation during application was provided by stirring with a magnetic stirrer or a spatula.
Form of test substance preparations:
The test substance was applied as a suspension for all applications.
The maximum suitable concentration tor application was 25%, due to its highly viscous, pasty consistence.

SELECTION OF THE VEHICLE
1 % CMC (cleaned sodium carboxymethylcellulose) in doubly distilled water was used as the vehicle because good homogeneity of the preparation was achieved.

RANGE FINDING TESTS:
The concentrations for the test substance suitable for use in the main experiment were determined in the pretest.
One 24-hour epicutaneous occlusive application was performed. 10% and 25% test substance preparations in 1 % CMC-solution in doubly distilled water were tested. No skin irritation could be noticed (findings 24 and 48 hours after removal of the patch).
Applicability: it was possible to inject a 5% test substance preparation in 1 % CMC-solution in doubly distilled water or 5% in Freund's adjuvant / 0.9% aqueous NaCI-solution (1 : 1) with a syringe. The concentration was weIl-tolerated Iocally and systemically.
The following concentrations for induction and the challenge were selected on the basis
of the pretest:
- Intradermal induction: Test substance 5% in 1 % CMC-solution in doubly distilled water or 5% in Freund's adjuvant / 0.9% aqueous NaCI-solution (1:1)
- Epicutaneous induction: Test substance 25% in 1 % CMC-solution in doubly distilled water
- Challenge: Test substance 25% in 1 % CMC-solution in doubly distilled water

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2, intradermal induction (6 intradermal injections in groups of two per animal were given): day 0; Epicutaneous induction: day 6
- Intradermal induction:
- Test groups: Test substance 5% in 1 % CMC-solution in doubly distilled water or 5% in Freund's adjuvant / 0.9% aqueous NaCI solution (1:1); Epicutaneous induction: Test substance 25% in 1 % CMC-solution in doubly distilled water
A) front row: 2 injections each of 0.1 ml Freund's adjuvant without test substance emulsified with 0.9% aqueous NaCI-solution in a ratio of 1 : 1
B) middle row: 2 injections each of 0.1 ml of a test substance formulation in an appropriate vehicle at the selected concentration
C) back row: 2 injections each of 0.1 ml Freund's adjuvant /0.9% aqueous NaCI-solution (1 : 1) with test substance at the selected concentration.
- Control group:
A) front row: 2 injections each of 0.1 ml Freund's adjuvant without test substance emulsified with 0.9% aqueous NaCI-solution in a ratio of 1 : 1
B) middle row: 2 injections each of 0.1 ml of the undiluted vehicle
C) back row: 2 injections each of 0.1 ml of a 50% formulation of the vehicle without test substance emulsified with Freund's adjuvant /0.9% aqueous NaCl-solution (1:1)
- Site: neck region
- Readings: 24 h after the beginning of application

EPICUTANEOUS INDUCTION:
- amount applied: 2 x 4 cm gauze patches (6 Iayers surgical gauze Ph. Eur. from Lohmann GmbH & Co.KG) containing the test substance formulation were applied to the skin of the neck region under an occlusive dressing. The dressing consisted of rubberized linen patches (4 x 6 cm from Russka) and Fixomull®Stretch (adhesive fleece) from Beiersdorf AG.
1 g of the test substance formulation was applied to each animal.
- The control animals were not treated since the 1 % CMC-solution in doubly distilled water used as formulating agent was not expected to influence the result of the study.
- Duration of exposure: 48 hours
- Site of application: neck region, same area as in the case of the previous intradermal application
- Readings: 48 h after the beginning of application

B. CHALLENGE EXPOSURE
The challenge was performed 14 days after the epicutaneous induction.
- No. of exposures: 1
- Amount applied: 2 x 2 cm gauze patches (6 Iayers surgical gauze Ph. Eur. from Lohmann GmbH & Co. KG) containing the test substance formulation were applied to the skin of the flank under an occlusive dressing. The dressing c onsisted of rubberized linen patches (4 x 4 cm from Russka), patches of Idealbinde (5 x 5 cm from Pfaelzische Verbandstoff-Fabrik) and Fixomull® Stretch (adhesive fleece) from Beiersdorf AG.
0.5 g of the test substance formulation was applied to each animal.
Ihe test group and the control group were treated with the test substance formulation.
- Duration of exposure: 24 hours
- Site of application: intact flank
- Removal of the test substance: with water / REDURAN® (special cleanser for dyes, Stockhausen, Krefeld)
- Evaluation (hr after challenge): 24 and 48 h after the removal of the patch


Challenge controls:
5 female animales, dose for challenge application: 0.5 g
Positive control substance(s):
yes
Remarks:
5% (intradermal inductuction and challenge), 10% (epicutaneous induct.) Alpha-Hexylcinnamaldehyde techn. 85% in Lutrol E400 (epicutanous induct. and challenge) /in paraffin oil resp. or Freund's adjuvant/0.9% aqu. NaCl-solution (1:1) (intradermal induct.)
Positive control results:
The positive control shows that Alpha-Hexylcinnamaldehyde techn. 85% has a sensitizing effect on the skin of the guinea pig in the Maximization Test under the test conditions chosen and is therefore able to detect sensitizing compounds.
Reading:
1st reading
Hours after challenge:
24
Group:
test group
Dose level:
25% in 1% CMC-solution in doubly distilled water
No. with + reactions:
2
Total no. in group:
10
Clinical observations:
Grade 1 (discrete or patchy erythema) according to the grading scale of Magnusson and Kligman (max. score 3)
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25% in 1% CMC-solution in doubly distilled water. No with. + reactions: 2.0. Total no. in groups: 10.0. Clinical observations: Grade 1 (discrete or patchy erythema) according to the grading scale of Magnusson and Kligman (max. score 3).
Reading:
2nd reading
Hours after challenge:
48
Group:
test group
Dose level:
25% in 1% CMC-solution in doubly distilled water
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no skin reactions
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25% in 1% CMC-solution in doubly distilled water. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no skin reactions.
Reading:
1st reading
Hours after challenge:
24
Group:
other: control group
Dose level:
25% in 1% CMC-solution in doubly distilled water
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no skin reactions
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group:
Reading:
2nd reading
Hours after challenge:
48
Group:
other: control group
Dose level:
25% in 1% CMC-solution in doubly distilled water
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no skin reaction
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group:
Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

There is a reliable study available to assess the skin sensitizing potential of the test substance.

The skin sensitizing potential of the test substance (purity: > 94.7 weight-%) was assessed based on the method of Magnusson and Kligman in a GLP conform study conducted according to OECD guideline 406 (BASF SE, 2003). Based on the results of a pretest and given that the test substance was highly viscous and pasty the maximal applicable concentration was 25%. The intradermal induction was performed with a 5 % test substance preparation in 1 % aqueous CMC-solution or 5 % test substance preparation in Freund's adjuvant/ 0.9 % aqueous NaCI-solution (1 : 1). The epicutaneous induction as well as the challenge were performed with a 25 % test substance preparation in 1 % aqueous CMC-solution.

The study was conducted with one control group (5 female animals) and one test group (10 female animals). The intradermal induction was performed on day 0, the epicutaneous induction on day 6 and the challenge was carried out 14 days after the epicutaneous induction.

The intradermal induction caused moderate and confluent to intense erythema and swelling at the injection sites of the test substance preparation in all test group animals. After the epicutaneous induction incrustation, partially open (caused by the intradermal induction) could be observed in addition to moderate and confluent erythema and swelling in all test group animals. The challenge caused discrete or patchy erythema in two test group animals, 24 hours after removal of the patch, but was reversible within 48 hours.

Based on the results of this study it was concluded that the test substance does not have a sensitizing effect on the skin of the guinea pig in the Maximization Test under the test conditions chosen.


Migrated from Short description of key information:
Key study, GPMT, guinea pig: not sensitizing (GLP, OECD 406, BASF SE, 2003)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Dangerous Substance Directive (67/548/EEC)

The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for skin sensitization under Directive 67/548/EEC, as amended for the 31st time in Directive2009/2/EG.

 

Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008

The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for skin sensitization under Regulation (EC) No. 1272/2008, as amended for the third time in Directive (EC 618/2012).